课题基金 / 基金详情

I-Corps: Novel Biodegradable Metals and Biomimetic Interfaces with Enhanced Strength and Bioactivity

I-Corps: Novel Biodegradable Metals and Biomimetic Interfaces with Enhanced Strength and Bioactivity
I-Corps:新型可生物降解金属和仿生界面,具有增强的强度和生物活性
批准号:
1840332
负责人:
Huinan Liu
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2019-12-31

项目摘要

项目成果

Huinan Liu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broader impact/commercial potential of this I-Corps project on healthcare, quality of life, and the medical device industry is tremendous. The novel technology and advancement of biodegradable metals and biomimetic interfaces will lead to next-generation medical devices and implants that promote tissue healing and eliminate secondary surgeries for implant removal. This will improve quality of life for patients who need medical implants to support bones and tissue damaged by disease or trauma, and reduce overall healthcare costs. The project will build the foundation for commercializing biodegradable metallic implants and devices, which, in turn, will increase the competitiveness of U.S. companies in the medical device industry. The products resulting from this project will reduce pain and complications, eliminate secondary surgeries, and accelerate healing and recovery for patients who need medical implants due to trauma or disease.This I-Corps project will advance technology that eliminates the drawbacks of the non-degradable medical alloys on the market today. Magnesium (Mg) based alloys are a novel class of biodegradable metallic materials that have attractive mechanical and biological properties for a wide range of medical implant applications, such as orthopedic, spinal, dental, and craniofacial implants. The key challenge in commercializing Mg-based alloys for medical implant applications lies in controlling the degradation rate. NSF support has contributed to a novel class of biocompatible Mg alloys along with biomimetic surface treatment to provide tunable degradation rates, desirable bioactivity, and excellent mechanical strength for supporting faster healing and regeneration of damaged tissues. This novel solution contains non-toxic natural elements that induce healing and reduce inflammation, departed from traditional alloy design. The I-Corps project will transform this technology to commercially viable products that will benefit the customers in need.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: Biodegradable Regenerative Spinal Implants
  • 批准号:
    2319774
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2023
  • 负责人:
    Huinan Liu
  • 依托单位:
UNS: Engineering Infection-Free Implants for Skeletal Reconstruction
  • 批准号:
    1512764
  • 项目类别:
    Standard Grant
  • 资助金额:
    $31.56万
  • 财政年份:
    2015
  • 负责人:
    Huinan Liu
  • 依托单位:
BRIGE: An Interdisciplinary Research and Education Program for Engineering Biodegradable Metallic Implants and Biomimetic Interfaces
  • 批准号:
    1125801
  • 项目类别:
    Standard Grant
  • 资助金额:
    $17.5万
  • 财政年份:
    2011
  • 负责人:
    Huinan Liu
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: